Novo Nordisk

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharmaceuticals. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

https://www.novonordisk.com/

Project Info

Date:

7 October 2020

Previous project

Next project

Overall coordination

Corporate access team for

Claudia Nanni, Event Manager, Tradinfo,
[email protected], +32 489 905 180

Continental European companies

Kepler Cheuvreux
Patrice Solaro, North America Corporate Access
[email protected]
+1 (347) 301-4119

Nordic companies

DNB Markets, Inc.
Kjersti Tufta, Corporate Access Manager
[email protected]
+1 646 283 8627

UK companies

Numis Securities
Megan O’Donovan, Manager, Investor Relations
[email protected]
+1 212 277 7323

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.